"El Instituto Universitario de Oftalmobiología Aplicada de la Universidad de Valladolid es un centro pionero, que nació en el seno de la Universidad de Valladolid hace 25 años, con una triple vertiente: Investigación, Formación y Clínica. “Investigamos para curar mejor”"

During the past decade, IOBA conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IOBA" #1 collaborator was "Fondo de Investigacion Sanitaria" with 2 trials as a collaborator, "Hospital Clínico Universitario de Valladolid" with 2 trials as a collaborator, "Red de Terapia Celular" with 2 trials as a collaborator, "University of Valladolid" with 2 trials as a collaborator and "Centro en Red de Medicina Regenerativa de Castilla y Leon" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "IOBA" are "Ocular Hypertension" (4 trials), "Diabetes Mellitus" (2 trials), "Open Angle Glaucoma" (2 trials), "Ataxia, Cerebellar" (1 trials) and "Choroidal Neovascularization" (1 trials). Many other conditions were trialed in "IOBA" in a lesser frequency.

Most popular intervention types in "IOBA" are "Drug" (8 trials), "Other" (3 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "1 drop of 0.375% SYL040012 (bamosiran)" (1 trials), "1 drop of 0.5 % timolol maleate" (1 trials), "1 drop of 0.750% SYL040012 (bamosiran)" (1 trials) and "1 drop of 1.125% SYL040012 (bamosiran)" (1 trials). Other intervention names were less common.

The vast majority of trials in "IOBA" are 17 trials for "All" genders.

Currently, there are NaN active trials in "IOBA". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in IOBA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IOBA, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".